TY - JOUR
T1 - γ-Interferon-induced monocyte major histocompatibility complex class II antigen expression in individuals with acquired immune deficiency syndrome
AU - Martínez-Maza, Otoniel
AU - Mitsuyasu, Ronald T.
AU - Miles, Steven A.
AU - Giorgi, Janis V.
AU - Heitjan, Daniel F.
AU - Sherwin, Stephen A.
AU - Fahey, John L.
PY - 1989/10/15
Y1 - 1989/10/15
N2 - Twelve patients with the acquired immune deficiency syndrome (AIDS) and Kaposi's sarcoma were treated with recombinant human γ-interferon (rIFN-γ). A rapid, substantial increase in the fraction of HLA-DQ-positive monocytes was noted after treatment with rIFN-γ. The rIFN-γ-induced increase in monocyte HLA-DQ was seen throughout the course of treatment, with the percentage of HLA-DQ-positive monocytes dropping slightly following each week's treatment with rIFN-γ and then rapidly increasing following the next course of treatment. Although the percentage of HLA-DR-positive monocytes was unchanged (HLA-DR was expressed on > 80% of monocytes prior to treatment), the density of HLA-DR on monocytes also increased following rIFN-γ treatment. Following rIFN-γ treatment, no changes were seen in CD3, CD4, CD8 T cell numbers, in T cell subset ratio (CD4/CD8), in Leu 7 or CD 16 (Leu 11) cell number, in spontaneous Ig secretion, in PHA-induced in vitro proliferation, or in NK activity. These results indicate that exposure to rIFN-γ in vivo led to the increased expression of class II antigens on monocytes in patients with AIDS.
AB - Twelve patients with the acquired immune deficiency syndrome (AIDS) and Kaposi's sarcoma were treated with recombinant human γ-interferon (rIFN-γ). A rapid, substantial increase in the fraction of HLA-DQ-positive monocytes was noted after treatment with rIFN-γ. The rIFN-γ-induced increase in monocyte HLA-DQ was seen throughout the course of treatment, with the percentage of HLA-DQ-positive monocytes dropping slightly following each week's treatment with rIFN-γ and then rapidly increasing following the next course of treatment. Although the percentage of HLA-DR-positive monocytes was unchanged (HLA-DR was expressed on > 80% of monocytes prior to treatment), the density of HLA-DR on monocytes also increased following rIFN-γ treatment. Following rIFN-γ treatment, no changes were seen in CD3, CD4, CD8 T cell numbers, in T cell subset ratio (CD4/CD8), in Leu 7 or CD 16 (Leu 11) cell number, in spontaneous Ig secretion, in PHA-induced in vitro proliferation, or in NK activity. These results indicate that exposure to rIFN-γ in vivo led to the increased expression of class II antigens on monocytes in patients with AIDS.
UR - http://www.scopus.com/inward/record.url?scp=0024436148&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024436148&partnerID=8YFLogxK
U2 - 10.1016/0008-8749(89)90292-X
DO - 10.1016/0008-8749(89)90292-X
M3 - Article
C2 - 2507169
AN - SCOPUS:0024436148
SN - 0008-8749
VL - 123
SP - 316
EP - 324
JO - Cellular Immunology
JF - Cellular Immunology
IS - 2
ER -